Literature DB >> 19336757

Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice.

Weili Bao1, Jin Yu, Susanne Heck, Karina Yazdanbakhsh.   

Abstract

Red blood cell alloimmunization remains a major complication for transfusion-dependent patients, but immune factors governing risk for alloimmunization are unknown. We hypothesized that CD4+ regulatory T cells (Tregs), which we have shown control the rate and the frequency of red blood cell alloimmunization in mouse models, may dictate responder/nonresponder status. Using a transfusion regimen in which more than 50% of mice develop alloantibodies to human glycophorin A antigen, we found reduced in vitro and in vivo Treg-suppressive activity in responders compared with nonresponders that was the result of impaired Treg suppressor function. Moreover, responders were prone to developing additional alloantibodies to strong immunogens, whereas nonresponders were resistant to alloimmunization. Altogether, our data raise the possibility that Treg activity may be used as a marker for identifying responder/nonresponder status in transfusion recipients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336757      PMCID: PMC4729534          DOI: 10.1182/blood-2008-12-193748

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

Authors:  E P Vichinsky; N L Luban; E Wright; N Olivieri; C Driscoll; C H Pegelow; R J Adams
Journal:  Transfusion       Date:  2001-09       Impact factor: 3.157

2.  CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia.

Authors:  Amina Mqadmi; Xiaoying Zheng; Karina Yazdanbakhsh
Journal:  Blood       Date:  2005-01-06       Impact factor: 22.113

3.  Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T-->C promoter mutation in non-erythroid tissues.

Authors:  Asok Chaudhuri; Genevieve Yuen; Flora Fang; Jill Storry
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

Review 4.  Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Authors:  Banu Aygun; Savitri Padmanabhan; Carole Paley; Visalam Chandrasekaran
Journal:  Transfusion       Date:  2002-01       Impact factor: 3.157

5.  Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?

Authors:  Henk Schonewille; Leo M G van de Watering; Anneke Brand
Journal:  Transfusion       Date:  2006-04       Impact factor: 3.157

6.  Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.

Authors:  Oswaldo Castro; S Gerald Sandler; Patricia Houston-Yu; Sohail Rana
Journal:  Transfusion       Date:  2002-06       Impact factor: 3.157

7.  Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.

Authors:  Jin Yu; Susanne Heck; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

8.  Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.

Authors:  John M Higgins; Steven R Sloan
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

9.  RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients.

Authors:  Reem Ameen; Salem Al-Shemmari; Salah Al-Humood; Rafiq I Chowdhury; Ohood Al-Eyaadi; Abdulaziz Al-Bashir
Journal:  Transfusion       Date:  2003-11       Impact factor: 3.157

Review 10.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  24 in total

1.  Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.

Authors:  Nicole H Smith; Eldad A Hod; Steven L Spitalnik; James C Zimring; Jeanne E Hendrickson
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Authors:  Elliott Vichinsky; Lynne Neumayr; Sean Trimble; Patricia J Giardina; Alan R Cohen; Thomas Coates; Jeanne Boudreaux; Ellis J Neufeld; Kristy Kenney; Althea Grant; Alexis A Thompson
Journal:  Transfusion       Date:  2013-07-25       Impact factor: 3.157

3.  Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major.

Authors:  Weili Bao; Hui Zhong; Xiaojuan Li; Margaret T Lee; Joseph Schwartz; Sujit Sheth; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2011-09-26       Impact factor: 10.047

4.  Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.

Authors:  David R Gibb; Jingchun Liu; Prabitha Natarajan; Manjula Santhanakrishnan; David J Madrid; Stephanie C Eisenbarth; James C Zimring; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

Review 5.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

6.  Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance.

Authors:  Rakchha Chhetri; Li Yan A Wee; Romi Sinha; Monika M Kutyna; Anh Pham; Helen Stathopoulos; Lakshmi Nath; Shriram V Nath; Nicholas Wickham; Tim Hughes; Deepak Singhal; David J Roxby; Devendra K Hiwase
Journal:  Haematologica       Date:  2019-02-28       Impact factor: 9.941

7.  The impact of vaccination on RBC alloimmunization in a murine model.

Authors:  P Natarajan; M Santhanakrishnan; C A Tormey; J E Hendrickson
Journal:  Vox Sang       Date:  2017-06-08       Impact factor: 2.144

8.  Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies.

Authors:  Sean R Stowell; Kathryn R Girard-Pierce; Nicole H Smith; Kate L Henry; C Maridith Arthur; James C Zimring; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2013-04-29       Impact factor: 3.157

9.  Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope.

Authors:  Krystalyn E Hudson; Eugene Lin; Jeanne E Hendrickson; Aron E Lukacher; James C Zimring
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

10.  Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.

Authors:  Gláucia A S Guelsin; Camila Rodrigues; Jeane E L Visentainer; Paula De Melo Campos; Fabíola Traina; Simone C O Gilli; Sara T O Saad; Lilian Castilho
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.